Skip to main content

Table 2 Summary of studies using the SF-36 to assess quality of life in patients with bipolar disorder1

From: Quality of life in bipolar disorder: A review of the literature

Study

Patient population

Physical

Social

Role physical

Role emotional

Pain

Mental health

General health

Vitality

Arnold (2000)

44 BD outpatients

78.8 ± 22.4

57.9 ± 27.7

63.1 ± 41.6

38.6 ± 43.1

64.9 ± 25.7

55.3 ± 23.8

61.9 ± 25.4

43.6 ± 24.3

Have (2002)2

93 BD type I

43 BD NOS

89.6

91.2

73.6

80.8

77.6

81.7

69.5

80.6

74.1

82.5

62.3

68.7

62.6

68.2

58.0

62.0

Leidy (1998)

34 euthymic

28 depressed

84.4 ± 20.2

72.2 ± 28.3

73.2 ± 18.2

29.3 ± 20.0

86.2 ± 28.0

32.3 ± 38.6

76.2 ± 31.2

8.3 ± 20.3

59.6 ± 29.0

54.7 ± 25.3

69.2 ± 17.9

33.4 ± 16.5

70.9 ± 20.7

58.0 ± 21.2

52.0 ± 16.2

20.4 ± 17.5

Namjoshi (2002)

122 BD type I (manic/mixed) 65 olanzapine 57 placebo

86.8 ± 16.8

84.5 ± 21.9

47.1 ± 28.3

46.0 ± 31.8

70.4 ± 40.2

65.4 ± 40.3

37.4 ± 42.3

36.3 ± 43.3

68.4 ± 26.4

61.7 ± 25.0

59.9 ± 22.6

58.5 ± 19.8

69.0 ± 22.7

65.2 ± 24.3

63.3 ± 24.0

66.6 ± 20.0

Patelis-Siotis (2001)

34 BD CBT completers

8 BD CBT non-completers

80.4 ± 19.3

63.8 ± 30.6

58.1 ± 25.0

46.9 ± 28.1

41.2 ± 39.8

40.6 ± 44.2

17.6 ± 33.1

29.2 ± 41.5

68.5 ± 23.7

63.4 ± 27.0

52.4 ± 18.0

44.0 ± 22.0

66.6 ± 21.7

46.4 ± 29.6

39.4 ± 19.3

28.1 ± 21.4

Revicki (1997)

14 BD patients (in-person)

14 BD patients (by telephone)

78.4 ± 25.2

77.0 ± 29.3

53.6 ± 30.2

57.1 ± 29.9

65.2 ± 38.7

59.8 ± 41.0

40.5 ± 42.9

33.3 ± 40.6

68.0 ± 31.8

69.3 ± 28.2

53.4 ± 22.8

53.9 ± 20.0

59.8 ± 22.8

57.5 ± 22.7

41.4 ± 18.7

41.4 ± 20.5

Tsevat (2000)

53 BD patients

78.7 ± 23.4

58.7 ± 27.9

63.2 ± 40.9

38.9 ± 42.3

65.3 ± 26.0

56.2 ± 23.7

62.1 ± 24.3

45.4 ± 24.4

Shi (2002)

453 BD type I

234 olanzapine 219 haloperidol

85.2 ± 23.2

90.5 ± 15.7

61.1 ± 31.8

61.2 ± 29.1

66.1 ± 39.6

72.8 ± 36.3

53.3 ± 43.1

50.1 ± 43.7

79.8 ± 26.2

81.2 ± 26.1

71.0 ± 20.4

72.8 ± 16.5

73.6 ± 21.8

75.1 ± 19.2

75.8 ± 19.1

80.0 ± 14.9

Shi (2004)

573 BD type I (currently depressed)

250 olanzapine

58 olanzapine/fluoxetine combination

265 placebo

65.8 ± 27.6

68.8 ± 25.0

66.6 ± 26.2

29.1 ± 20.9

30.6 ± 20.8

32.5 ± 21.4

47.8 ± 44.0

44.8 ± 41.8

46.4 ± 42.3

12.9 ± 25.4

9.8 ± 23.4

14.6 ± 28.7

60.6 ± 27.1

60.8 ± 25.6

57.8 ± 26.1

30.0 ± 16.1

31.0 ± 17.3

31.3 ± 15.7

51.1 ± 22.3

52.3 ± 20.7

48.6 ± 22.6

25.5 ± 17.5

25.3 ± 19.0

25.6 ± 17.6

Yatham (2004)

920 BD type I (currently depressed/ depressive episode in previous 60 days)

70.2 ± 26.2

29.9 ± 22.8

36.7 ± 40.9

11.4 ± 23.5

62.2 ± 27.1

31.0 ± 17.3

47.5 ± 23.3

22.4 ± 17.7

  1. 1 Data presented as mean ± SD
  2. 2 SDs not available